National Haemoglobinopathy Panel
Providing expert and evidence-based advice on the management of adults and children with Sickle Cell Disease, Thalassaemia and Rare Inherited Anaemias, as and when requested by the clinicians caring for these patients.
Driving Innovation and Quality
The NHP will monitor relevant data at a national level and promote access to novel therapies and clinical trials for all patients, regardless of geography.